Articles From: Avago Technologies Limited Announces Fourth Quarter and Fiscal Year 2014 Financial Results to Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock


Quarterly net revenue from continuing operations up 25 percent sequentially Quarterly GAAP gross margin from continuing operations of 50 percent; Quarterly Non-GAAP gross margin from continuing operations of 58 percent Quarterly GAAP diluted EPS from continuing operations of $0.50; Quarterly Non-GAAP diluted EPS from continuing operations of $1.99 SAN JOSE, Calif.
Sign-up for Avago Technologies Limited Announces Fourth Quarter and Fiscal Year 2014 Financial Results investment picks
GAAP gross margin from continuing operations of 31 percent; Non-GAAP gross margin from continuing operations of 57 percent GAAP diluted EPS loss of $0.65; Non-GAAP diluted EPS from continuing operations of $1.26 Fourth fiscal quarter revenue from continuing operations projected to be up 18-22% sequentially SAN JOSE, Calif., and SINGAPORE, Aug.
Sign-up for Avago Technologies Limited Announces Third Quarter Fiscal Year 2014 Financial Results investment picks
2014/12/4
Seppy Basili, Kaplan Test Prep’s vice president of college admissions and K12 programs, is available to speak with interested journalists regarding the company’s participation in today’s White House College Opportunity Day of Action and Kaplan’s commitment to the First Lady’s “Reach Higher” Campaign.
Sign-up for Available for Interview: Kaplan College Admissions Expert on Committing College Readiness Resources to FLOTUS Reach Higher Campaign investment picks
MENLO PARK, Calif., Oct.
Sign-up for Avalanche Biotechnologies to Participate in Gene Therapy Panel at the BIO Investor Forum investment picks
MENLO PARK, Calif., Oct.
Sign-up for Avalanche Biotechnologies to Participate in Nomura's Biotechnology Conference investment picks
MENLO PARK, Calif., Nov.
Sign-up for Avalanche Biotechnologies to Present at the 26th Annual Piper Jaffray Healthcare Conference investment picks
MENLO PARK, Calif., Nov.
Sign-up for Avalanche Biotechnologies to Present at the Jefferies Global Healthcare Conference investment picks
MENLO PARK, Calif., Sept.
Sign-up for Avalanche Biotechnologies to Present at the NewsMakers in the Biotech Industry Conference investment picks
MENLO PARK, Calif., Sept.
Sign-up for Avalanche Biotechnologies, Inc. Reports Second Quarter 2014 Financial Results investment picks
MENLO PARK, Calif., Nov.
Sign-up for Avalanche Biotechnologies, Inc. Reports Third Quarter 2014 Financial Results investment picks
2014/12/2
WARREN, Ohio , Dec.
Sign-up for Avalon Holdings Corporation Announces Organizational Changes investment picks
2014/11/13
WARREN, Ohio , Nov.
Sign-up for Avalon Holdings Corporation Announces Third Quarter Results investment picks
AVALONBAY COMMUNITIES, INC.
Sign-up for AvalonBay Communities Announces Third Quarter 2014 Earnings Release Date investment picks
AvalonBay Communities, Inc. (NYSE: AVB) (the “Company”) announced today that it priced a $300 million offering of unsecured notes (the “Notes”) with a maturity of November 15, 2024 under its existing shelf registration statement.
Sign-up for AvalonBay Communities Prices $300 Million Unsecured Notes Offering investment picks
AvalonBay Communities, Inc. (NYSE: AVB) announced today that Terry S.
Sign-up for AvalonBay Communities, Inc. Announces Appointment of Terry S. Brown as New Independent Director investment picks
AvalonBay Communities, Inc. (NYSE: AVB) (the “Company”) reported today Net Income Attributable to Common Stockholders for the quarter ended September 30, 2014 of $241,100,000. This resulted in Earnings per Share – diluted (“EPS”) of $1.83 for the three months ended September 30, 2014, compared to a loss of $0.08 per share for the comparable period of 2013.
Sign-up for AvalonBay Communities, Inc. Announces Third Quarter 2014 Operating Results investment picks
AvalonBay Communities, Inc. (NYSE: AVB) announced today that its Board of Directors declared a cash dividend on the Company’s Common Stock (par value $0.01 per share) for the fourth quarter of 2014.
Sign-up for AvalonBay Communities, Inc. Declares Fourth Quarter 2014 Dividends investment picks
AvalonBay Communities, Inc. (NYSE: AVB) (the “Company”) today announced the release of its annual corporate social responsibility (CSR) report .
Sign-up for AvalonBay Issues Annual Corporate Social Responsibility Report investment picks
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether members of the board of directors of Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) breached their fiduciary duties in connection with the planned merger of the Company with Otsuka Pharmaceutical Co., Ltd.
Sign-up for AVANIR ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Avanir Pharmaceuticals, Inc. to Otsuka Pharmaceutical investment picks
--Study Demonstrated Clinically Meaningful and Statistically Significant Improvement of Agitation in Patients with Alzheimer's Disease--
Sign-up for Avanir Pharmaceuticals Announces Presentation of AVP-923 Phase II Results in Agitation in Patients with Alzheimer's Disease at the American Neurological Association Meeting investment picks
ALISO VIEJO, Calif.
Sign-up for Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock investment picks
ALISO VIEJO, Calif.
Sign-up for Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Avago Technologies Limited Announces Fourth Quarter and Fiscal Year 2014 Financial Results to Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent